1. A Qualitative Review of Neoadjuvant Chemotherapy in Resectable Pancreatic Adenocarcinoma
   Alex B. Blair et al, 2019, Pancreas CrossRef
2. Neoadjuvant multimodal treatment of pancreatic ductal adenocarcinoma
   Nicola Silvestris et al, 2016, Critical Reviews in Oncology/Hematology CrossRef
3. Multimodal treatment of resectable pancreatic ductal adenocarcinoma
   Nicola Silvestris et al, 2017, Critical Reviews in Oncology/Hematology CrossRef
4. Neoadjuvant treatment of pancreatic adenocarcinoma: a systematic review and meta-analysis of 5520 patients
   Mashaal Dhir et al, 2017, World Journal of Surgical Oncology CrossRef
5. Neoadjuvant therapy in resectable pancreatic cancer: A promising curative method to improve prognosis
   Hao-Qi Zhang et al, 2022, World Journal of Gastrointestinal Oncology CrossRef
6. Neoadjuvant treatment for resectable pancreatic adenocarcinoma
   John Wong, 2016, World Journal of Clinical Oncology CrossRef
7. Neoadjuvant Therapy is Essential for Resectable Pancreatic Cancer
   Jin-Zhi Xu et al, 2020, Current Medicinal Chemistry CrossRef
8. Hepatic arterial infusion chemotherapy with gemcitabine and 5-fluorouracil or oral S-1 improves the prognosis of patients with postoperative liver metastases from pancreatic cancer
   HIDEHIRO TAJIMA et al, 2013, Molecular and Clinical Oncology CrossRef
9. Neoadjuvant chemotherapy with gemcitabine‑based regimens improves the prognosis of node positive resectable pancreatic head cancer
   Hidehiro Tajima et al, 2019, Molecular and Clinical Oncology CrossRef
10. Neoadjuvant therapy for resectable pancreatic cancer: a narrative review
    Chengfang Wang et al, 2022, Journal of Pancreatology CrossRef
11. The Chinese guidelines for neoadjuvant therapy of pancreatic cancer (2020)
    Taiping Zhang et al, 2021, Journal of Pancreatology CrossRef